Biopharma predictions 2022

Updated: Feb 3



If you haven't already heard of Paul Simms before, chances are you'll have heard of one or two of his predictions for the industry, which he presents live every January.


Paul doesn't seek to play to popular narratives, and enjoys being brave and sometime outlandish in his approach - even going so far as to review his previous years predictions and highlight where he went wrong (and right) in the previous year.


Like all good science fiction, the process of predicting is way more powerful than getting it right...


Read the full report here


2022 Predictions by Paul Simms copy
.pdf
Download PDF • 3.55MB

___


This is part of a series of posts by LUCENT biopharma – focused on the future of medicines and their marketing in the biopharma sector.


For more information, please go to www.lucentbiopharma.com

3 views0 comments

Recent Posts

See All

With endless meetings, incessant emails, and casts of thousands, companies have mastered the art of unnecessary interactions. Winning in the next normal requires much more focus on true collaboration.

Don't let great ideas die over and over again because they're not being sold well. ___ This is part of a series of posts by LUCENT biopharma – focused on the future of medicines and their marketing in